Contents
  1. Antibody response and treatment success in dogs with Brucella canis – experience report from small animal practice and current guideline
  2. Why Brucella canis must now be considered in every small animal practice
  3. FAQs about Brucella canis in practice
  4. Comprehensive summary for owners: What you need to know about Brucella canis and how we can act together.
  5. Sources & further guidelines (selection)
  6. About the author

Antibody response and treatment success in dogs with Brucella canis – experience report from small animal practice and current guideline

Why Brucella canis This must now be considered in every small animal practice.

As a veterinarian and medical director of our small animal practices in Karlovy Vary, having studied in Leipzig, I have dealt with several cases of in recent years. Brucella canis seen – often under the radar, frequently only discovered when a dog is brought in due to recurring paralysis, back pain or Discospondylitis is presented. Brucella canis is a zoonotic Brucella species, which occurs worldwide and does not only affect breeding stock or imported dogs. It is crucial for owners to understand that this infection can become chronic, is therapeutically challenging, and requires consistent monitoring – ideally with quantitative antibody tests that detect treatment response and relapses early.

In diagnostics, in addition to classical serological tests, a multiplex-based antibody test (CBM assay) established BP26 and PO1 It uses target antigens and thus objectifies monitoring of disease progression. In a publication (AJVR, 2025), they correlated PO1 decreases after 60–185 days significantly with clinical treatment success. In practice, this means: We can do that Therapy monitoring to evaluate in a more structured and earlier manner than is possible with clinical parameters and standard serologies alone.

Brucella Canis
Brucella Canis 2

Clinical picture: Not just reproduction – often orthopedics and neurology

Classically, one knows Brucella canis from the reproductive sphere (resorptions, abortions, stillbirths; in male dogs epididymitis/orchitis), but dominate in small animal practice Musculoskeletal and spinal symptomsintermittent Lameness, Back or hip pain, nonspecific performance weakness. Imaging often leads to Discospondylitis – here should Brucella canis It should be a top consideration in the differential diagnosis, especially in young dogs or rescue/imported dogs. Case series studies show that B. canis discospondylitis is clinically and radiologically variable – all the more reason to test systematically and not stop after a single negative result.

Test strategy: From screening to confirmation – and then to progress

For Brucella canis applies serial test strategy: Screening with RSAT (Rapid Slide Agglutination Test) and – better yet – 2ME-RSAT (with 2-mercaptoethanol to reduce non-specific agglutinins), Confirmation with AGID II (Agar-gel immunodiffusion), ideally in a reference laboratory. Culture/PCR are possible, but not always sensitive in practice, especially outside of bacteremia. The CBM assay (Multiplex) complements the toolbox, providing quantitative antibody values (among other things). PO1) and is therefore ideally suited for the Therapy monitoring. Important: A single negative test result does not rule out infection – Repetition and Parallel tests are indicated in cases of clinical suspicion.

A proven practice procedure:

  1. Medical history & risk profile (Import/animal welfare, breeding use, contact with positively tested dogs, clinical indications of discospondylitis).
  2. Screening: 2ME-RSAT ± RSAT.
  3. Confirmation: AGID II in the reference laboratory (high specificity).
  4. Extension In cases of strong suspicion: culture/PCR from blood, semen, vaginal swab; repeat tests at intervals.
  5. Baseline quantification: CBM assay (incl. PO1), then Progress measurements after 2–6 months.
  6. Zoonosis risk consultation and check official requirements/reporting obligations.

Therapy: Why monotherapy with doxycycline is not enough

There are no internationally standardized protocol. We usually rely on Polytherapy (e.g. doxycycline combined with a fluoroquinolone or an aminoglycoside in clearly defined phases), accompanied by analgesia and consistent management (rest, orthoses if necessary, physiotherapy). Monotherapy with doxycycline alone is Not recommended, The intracellular persistence of Brucella bacteria promotes relapses. Antibiotic choice and duration depend on the course of the illness, tolerability, comorbidities, and – crucially – on… Antibody dynamics in the CBM assay. A PO1 antibody levels decrease by ~40 mg/% after 2–6 months This is considered an indication of a good response. Nevertheless, the Eradication unsure; Recruits are possible.

Public health, reporting requirements & communication with owners

Brucella canis is a Zoonosis. Human medicine assesses exposures in a differentiated way; the CDC National public health guidelines describe testing, exposure, and prevention strategies. This is the case in several countries. Reporting obligation or official obligation to cooperate; in Germany, the regulation of brucellosis is species-dependent, while international regulations vary. Practical relevance: Contact reduction, Hygiene, information for particularly vulnerable people (immunosuppressed individuals, pregnant women, children). In Great Britain, the Specifications updated for 2025 and emphasize the importance of monitoring imported dogs. Use official guidelines and coordinate household screenings early.

Real-world reality: Long-distance running instead of sprinting – why trend data counts

During my consultation hours, I clearly explain to Haltern: Brucella canis means Long-term management. We define Decision points (T0, 8–12 weeks, 16–24 weeks) and couple clinical goals (Pain-free, mobility, neurological stability) with serological targets (e.g. ≥ 40 % PO1 declineIn case of stagnation or increase, the regime is adjusted; Recruitment A rapid re-staging, including imaging and repeat testing, is carried out. In complex cases, cooperation with zoonosis specialists, neurology, radiology, and – if necessary – the authorities is helpful.

FAQs about Brucella canis in practice

1) My dog has recurring back pain and lameness. When should I consult a veterinarian? Brucella canis How do I think about it and how do I proceed?

Think about Brucella canis, if a dog – especially a young, imported or rescue dog – recurrent lameness, Back/hip pain or neurological abnormalities shows phenomena that cannot be plausibly explained. At radiologically/CT/MRI confirmed discospondylitis heard Brucella canis into the first line of differential diagnoses. In my practice, I start with a series-based test strategy: 2ME-RSAT as a screening and AGID II for confirmation in the reference laboratory. negative individual result I do not end the diagnostic process if the clinical suspicion is high – I repeat the tests or combine them with other methods. PCR/Culture (e.g., blood, semen). In parallel, I am collecting a Baseline by CBM assay (BP26/PO1) to objectively monitor therapy progress. Additionally, Hygiene measures and a Zoonosis awareness essential for the household; depending on the country Reports required. This structured approach prevents infections from being overlooked and enables later intervention. Therapy fine-tuning based quantitative antibody trends.

2) Is doxycycline alone sufficient – or do I always need combination therapies? Brucella canis?

Short: Monotherapy with doxycycline is Not recommended. Brucella canis persists intracellular, forms Biofilm-like niches and shows intermittent bacteremia – Reasons why Relapses despite an initial positive response, these symptoms are common. Therefore, in practice, we rely on... Polytherapy, e.g. doxycycline plus Fluoroquinolone or in defined phases Aminoglycoside (subject to a strict benefit-risk assessment). The decisive factor is the Length of time (several months) and that MonitoringI rate clinical parameters (Pain, neurological status, performance) and the PO1 dynamics in the CBM assay. One Decrease of approximately 40 % after 2–6 months is a cheaper marker, However, it does not guarantee eradication. If antibody levels remain high or rise again, I will check. Compliance, resistance, Pharmacokinetics (Weight, kidney/liver function) and possible Cofactors (e.g. simultaneous fungal infections in endemic areas) before I adjust the regimen.

3) How reliable are the tests – and how do I implement them? CBM assay, RSAT/2ME-RSAT and AGID II Does that make sense?

Every test has strengths and limitations. RSAT/2ME-RSAT suitable as rapid screening. 2ME reduces nonspecific reactions, thus improving the Specificity versus RSAT alone; false positives However, they are possible. AGID II offers as Confirmation test one high specificity, However, it is not available in every routine laboratory and requires reference laboratories. Culture/PCR can provide direct evidence, but are dependent on Sample selection and Time of bacteremia. The CBM assay is quantitatively and detects antibodies against BP26 and PO1; Studies report good performance data and – crucial for everyday practice – a useful progression diagram under therapy. In my routine I combine Screening + Confirmation with quantitative progress monitoring, Document trends and correlate them with clinical findings. multi-stage approach reduces misjudgments and prevents premature termination of therapy.

4) Is Brucella canis Dangerous for humans – and what does that mean for my household?

Yes. Brucella canis is zoonotic. The actual risk depends on Type of exposure, Infection burden and Household constellation off. Especially immunosuppressed individuals, Pregnant women and Children should be consistently protected. Hygiene rules include: contact with reproductive material (Semen, vaginal secretions, obstetrics) avoid, wear gloves when cleaning, Wound protection, Hand hygiene, separation of the Sleeping and lounging places. In confirmed cases, I inform the owners about Public health guidelines (e.g. CDC), discuss Screening of contact dogs (household/breeding) and – if required – Reports to the relevant authorities. In some countries, guidelines have been established. 2025 updated (e.g. UK), which, among other things, address the rise in imported cases. The goal is not panic, but objective risk management with clear procedures to ensure the safety of both dog and household.

5) When is euthanasia an option – and how can it be implemented? Long-term management How can we design it under fair conditions?

The decision for a euthanasia is individual, ethically demanding, and depends on clinical burden, Zoonotic risk, Husbandry conditions (e.g. keeping multiple dogs, breeding), Therapy adherence and Forecast ab. In my experience, euthanasia not the standard route; it can be considered if, despite adequate polytherapy and strict measures Recruits with significant suffering or when a acceptable zoonosis risk management in the household not possible is. In all other cases, I favor a transparent long-term management: clear Milestones (T0/3/6 months), CBM checks (PO1 curve), structured Analgesia/Physiotherapy, Environmental and hygiene rules, Screening of contact dogs, as well as the integration of the Human medicine in high-profile individuals. Openness about Uncertainties (No guaranteed eradication) prevents later disappointments and enables responsible decisions in the best interests of the animal and the family.

Comprehensive summary for owners: What you need to know Brucella canis know and how we act together

Brucella canis is a widely distributed worldwide bacterial infection in dogs, known as Zoonosis This can also affect people. In practice, we see... Brucella canis not only in breeding, but increasingly also in Family dogs, often with orthopedic-neurological symptoms. Typical clinical scenarios are recurrent back or hip pain, Lameness and recurring Performance weakness; imaging often reveals a Discospondylitis. Those who recognize these signals and Brucella canis Thinking ahead early prevents delays in diagnosis and therapy. Brucella canis This does not automatically mean a catastrophe for owners, but it does require patience, clarity and consequence.

Diagnostically, a Step-by-step plan central. We begin with Screening tests (RSAT/2ME-RSAT) and confirm positive or borderline findings with AGID II in the reference laboratory. Brucella canis It can evade direct detection; therefore, depending on the case, we supplement – PCR/Culture as well as Repeat tests. A Game-changer In clinical practice, the CBM assayHe measures antibodies against BP26 and PO1 and allows quantitative comparisons of trends. For owners, the rule of thumb is particularly easy to grasp: Takes PO1 to 2–6 months Therapy to approximately 40 % that speaks in favor of favorable course – however, without any guarantee of complete eradication. Brucella canis can persist and later recruit, for what reason continuity indispensable in controls and hygiene.

Therapeutically, Brucella canis no sprint, rather long distance. Monotherapy with doxycycline not proven; are common Combination regime above several months, adapted to clinical development and Antibody dynamics. We manage in parallel pain and inflammation, stabilize the musculoskeletal system and plan Rehabilitation realistic. Brucella canis Furthermore, it requires Zoonosis Management: Informing all household members, Hand hygiene, Contact reduction potentially infectious secretions, clean Wound management and – where required – Report to authorities. Guidelines of the CDC and European institutions offer clear guidance which we implement on a case-by-case basis. Brucella canis is manageable if Veterinary practice and Household act in partnership.

It is important to, Brucella canis not only as medical, but also as organizational Understanding the challenge. We define Milestones: Start (T0), 8–12 weeks, 16–24 weeks – each with clinical trial and CBM control. They appear affordable trends (e.g., PO1 decrease) and clinical improvement, we will stay the course; at Plateaus or deterioration We fit Antibiotic regimens and Supportive therapies to. Brucella canis required transparency In communication: realistic expectations, clear tasks (medication administration, appointments, hygiene steps), unambiguous „"If-then" agreements for relapses. This way it remains Brucella canis Predictable – even over months.

For some households Brucella canis Despite all measures, the burden may be too high, for example in the case of Breeding farms with many contacts or when Immunosuppressed living in the household. Then we talk openly about Alternatives, including euthanasia as the most difficult option – and make decisions based on Suffering, Zoonotic risk and Feasibility the measures.

In most cases, however, a stable everyday life, if Brucella canis is consistently managed: regular checks, adapted therapy, Hygiene discipline. As a veterinarian with many years of experience in internal medicine and ongoing training in surgery and infectiology, I provide structured support to pet owners through this time – with the goal of, Brucella canis to keep clinically calm and the Quality of life to secure the dog. Brucella canis It remains a challenge, but it is controllable, when knowledge, planning and cooperation come together.

Sources & further guidelines (selection)

About the author

Susanne Arndt, Veterinarian, Medical Director / Owner
Studies: Faculty of Veterinary Medicine, University of Leipzig
Career path: 6 years as assistant veterinarian at the small animal clinic of Dr. Thomas Graf (Cologne); 1 year setting up the small animal department at the Lahr Animal Health Center; since 2013 owner of the small animal practices in Karlsbad-Ittersbach/Karlsbad-Langensteinbach
Further education: Master of Small Animal Science (FU Berlin); ongoing professional development, including osteosynthesis
Memberships: German Veterinary Medical Society; Working Group on Feline Medicine of the DGK-DVG; Working Group on Laser Medicine of the DGK-DVG

Related posts:

  1. Dog pain
  2. Hypertrophic gastritis in dogs
  3. Tick protection for dogs
  4. Colon cancer in dogs
Scroll to Top